MedPath

Molev

Brand Name: Molev

Generic Name: Montelukast (as sodium) + Levocetirizine hydrochloride

Active
Registration Number

DR-XY48076

Dosage Form

Film Coated Tablet

Issuance Date

June 1, 2022

Expiry Date

June 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg/ 5 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 10's (Box of 10's) as Physician's Sample

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Leukotriene Receptor Antagonist
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Montelukast (as sodium)Active
Levocetirizine hydrochlorideActive
Monograph: Levocetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform